243 related articles for article (PubMed ID: 36369089)
21. lncRNA NORAD, soluble ICAM1 and their correlations may be related to the regulation of the tumor immune microenvironment in laryngeal squamous cell carcinoma (LSCC).
Horozoglu C; Bal G; Kabadayı B; Hakan MT; Sönmez D; Nacarkahya G; Verim A; Yaylım İ
Pathol Res Pract; 2023 Jun; 246():154494. PubMed ID: 37172522
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expressed long non-coding RNAs in laryngeal squamous-cell carcinoma.
Li H; Wang FL; Li W; Fei YH; Wang YT; Zhang JE; Bi HY; Zhang M
Am J Otolaryngol; 2019; 40(5):615-625. PubMed ID: 31128861
[TBL] [Abstract][Full Text] [Related]
23. A preliminary analysis of prognostic genes in advanced laryngeal squamous cell carcinoma patients with postoperative radiotherapy.
Hu C; Lao Z; Yan L; Song X; Wang J
Pathol Res Pract; 2023 Jan; 241():154229. PubMed ID: 36509010
[TBL] [Abstract][Full Text] [Related]
24. LAMP1 expression is associated with malignant behaviours and predicts unfavourable prognosis in laryngeal squamous cell carcinoma.
Lu M; Zhu H; Wang X; Zhang D; Xiong L; Zhu J; Mao Y; Qiang J
Pathology; 2016 Dec; 48(7):684-690. PubMed ID: 27788920
[TBL] [Abstract][Full Text] [Related]
25. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
[TBL] [Abstract][Full Text] [Related]
26. Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
Shi Y; Zhang Q; Xie M; Feng Y; Ma S; Yi C; Wang Z; Li Y; Liu X; Liu H; Yang H; Yan Y; Zhang Y; Ren X; Luo H
Oncol Rep; 2020 Dec; 44(6):2503-2516. PubMed ID: 33125127
[TBL] [Abstract][Full Text] [Related]
27. The analysis of tumor-infiltrating immune cell and ceRNA networks in laryngeal squamous cell carcinoma.
Li D; Dong K; Su J; Xue H; Tian J; Wu Y; Wang J
Medicine (Baltimore); 2022 Aug; 101(31):e29555. PubMed ID: 35945754
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.
Fang R; Huang Y; Xie J; Zhang J; Ji X
Diagn Pathol; 2019 Oct; 14(1):109. PubMed ID: 31615536
[TBL] [Abstract][Full Text] [Related]
29. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
[TBL] [Abstract][Full Text] [Related]
30. Correlation between expression of Lin28B and C-myc in patients with laryngeal squamous cell carcinoma and clinicopathological features and prognosis.
Liao F; Cao Y; Huang M; Chu L; Wang T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 48(2):165-171. PubMed ID: 36999462
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA profiling in laryngeal squamous cell carcinoma and its clinical significance: potential biomarkers for LSCC.
Shen Z; Li Q; Deng H; Lu D; Song H; Guo J
PLoS One; 2014; 9(9):e108237. PubMed ID: 25243407
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of UHRF1 is significantly associated with poor prognosis in laryngeal squamous cell carcinoma.
Pi JT; Lin Y; Quan Q; Chen LL; Jiang LZ; Chi W; Chen HY
Med Oncol; 2013 Dec; 30(4):613. PubMed ID: 24005809
[TBL] [Abstract][Full Text] [Related]
33. Serum-derived extracellular vesicles mediate Smad4 expression through shuttling microRNA-27a in the progression of laryngeal squamous cell carcinoma.
Shuang Y; Yao X; Liu J; Niu J; Guo W; Li C
Hum Cell; 2022 Jul; 35(4):1084-1099. PubMed ID: 35545731
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological significance of SOX4 and epithelial-mesenchymal transition markers in patients with laryngeal squamous cell carcinoma.
Zhang M; Li H; Han Y; Wang M; Zhang J; Ma S
Medicine (Baltimore); 2021 Mar; 100(12):e25028. PubMed ID: 33761659
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
[TBL] [Abstract][Full Text] [Related]
36. Long intergenic non-protein coding RNA 847 promotes laryngeal squamous cell carcinoma progression through the microRNA-181a-5p/zinc finger E-box binding homeobox 2 axis.
Li W; Hu X; Huang X
Bioengineered; 2022 Apr; 13(4):9987-10000. PubMed ID: 35435130
[TBL] [Abstract][Full Text] [Related]
37. Roles of KAI1 and nm23 in lymphangiogenesis and lymph metastasis of laryngeal squamous cell carcinoma.
Zheng Z; Tian R; Wang P
World J Surg Oncol; 2017 Nov; 15(1):211. PubMed ID: 29187211
[TBL] [Abstract][Full Text] [Related]
38. Increased methylation of ZNF671 suppresses tumor progression by promoting MAPK6 transcription in laryngeal carcinoma.
Zhang W; Liu T; Li X; Li T; Ma X; Zhao D; Zhao X
Int J Biol Sci; 2023; 19(8):2443-2457. PubMed ID: 37215982
[No Abstract] [Full Text] [Related]
39. Cyr61/CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis.
Liu Y; Zhou YD; Xiao YL; Li MH; Wang Y; Kan X; Li QY; Lu JG; Jin DJ
Asian Pac J Cancer Prev; 2015; 16(7):2659-64. PubMed ID: 25854342
[TBL] [Abstract][Full Text] [Related]
40. Preliminary study using a small plasma extracellular vesicle miRNA panel as a potential biomarker for early diagnosis and prognosis in laryngeal cancer.
Zhang H; Chen Z; Huang Q; Guo Y; Wang M; Wu C
Cell Oncol (Dordr); 2023 Aug; 46(4):1015-1030. PubMed ID: 36964893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
